Home › Sikkelcelziekte › Alabama › Birmingham
Sikkelcelziekte klinische studies in Birmingham, AL
14 studies voor Sikkelcelziekte zoeken deelnemers op locaties in en rond Birmingham (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
RekruterenFase 3
- University Of Alabama, Birmingham
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
RekruterenFase 1
- University of Alabama at Birmingham, Birmingham
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
RekruterenFase 3
- Uni of Alabama at Birmingham, Birmingham
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
RekruterenFase 1/2Gezonde vrijwilligers welkom
- University of Alabama Birmingham, Birmingham
SCD Stem Cell Mobilization and Apheresis Using Motixafortide
RekruterenFase 1
- University of Alabama at Birmingham, Birmingham
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
RekruterenFase 1/2Gezonde vrijwilligers welkom
- University of Alabama at Birmingham, Birmingham
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
RekruterenFase 3
- University of Alabama at Birmingham- Site Number : 8400003, Birmingham
Early Life Exposures Among Children With Sickle Cell Disease
Rekruteren
- University of Alabama at Birmingham, Birmingham
Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
RekruterenFase 4
- University Of Alabama, Birmingham
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
RekruterenObservatieonderzoek
- Children's of Alabama (MRD-HCT), Birmingham
- Children's of Alabama (NT-DMT), Birmingham
Cognitive Remediation Intervention to Prepare for Transition of Care
RekruterenFase 2
- University of Alabama at Birmingham, Birmingham
A Long-term Follow-up Study in Patients Who Received BEAM-101
RekruterenObservatieonderzoek
- University of Alabama at Birmingham, Birmingham
HPC Offered for PRESERVE Expansion
RekruterenObservatieonderzoek
- University of Alabama, Birmingham, Birmingham
Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
RekruterenObservatieonderzoek
- University of Alabama, Birmingham (UAB), Birmingham
Sikkelcelziekte studies in andere steden
- Atlanta, GA22 studies
- Washington, DC20 studies
- Memphis, TN18 studies
- Chicago, IL18 studies
- Philadelphia, PA15 studies
- New York City, NY13 studies
- St. Louis, MO12 studies
- Durham, NC10 studies
- Cincinnati, OH10 studies
- Boston, MA10 studies
- Houston, TX10 studies
- Pittsburgh, PA9 studies
Andere studies in Birmingham
- Kanker (alle vormen)30 studies
- Borstkanker24 studies
- Obesitas23 studies
- Eierstokkanker23 studies
- Niet-kleincellige longkanker22 studies
- Acute myeloïde leukemie21 studies
- Multipel myeloom18 studies
- COPD17 studies
- Cardiovasculaire ziekte17 studies
- Overgewicht16 studies
- Endometriumkanker16 studies
- Type 2-diabetes16 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.